Literature DB >> 18183463

Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean?

Angelita Habr-Gama1, Rodrigo O Perez, Igor Proscurshim, Viviane Rawet, Diego D Pereira, Afonso H S Sousa, Desiderio Kiss, Ivan Cecconello.   

Abstract

PURPOSE: The number of retrieved lymph nodes during radical surgery has been considered of great importance to ensure adequate staging and radical resection. However, this finding may not be applicable after neoadjuvant therapy in which, not only is there a decrease in lymph nodes recovered, but also a subgroup of patients with absence of lymph nodes in the resected specimen.
METHODS: Patients with absence of lymph nodes were compared with patients with ypN0 disease and patients with ypN+ disease.
RESULTS: Thirty-two patients (11 percent) had absence of lymph nodes, 171 patients (61 percent) had ypN0 disease, and 78 patients (28 percent) had ypN+ disease. Patients with absence of lymph nodes had significantly lower ypT status (ypT0-1, 40 vs. 13 percent; P<0.001) and decreased risk of perineural invasion (6 vs. 21 percent; P=0.04) compared with ypN0 patients. Five-year disease-free survival (74 percent) was similar to patients with ypN0 (59 percent; P=0.2), and both were significantly better than patients with ypN+ disease (30 percent; P<0.001).
CONCLUSIONS: Absence of lymph nodes retrieved from the resected specimen is associated with favorable pathologic features (ypT and perineural invasion status) and good disease-free survival rates. In this setting, absence of retrieved lymph nodes may reflect improved response to neoadjuvant chemoradiation therapy rather than inappropriate or suboptimal oncologic radicality.

Entities:  

Mesh:

Year:  2008        PMID: 18183463     DOI: 10.1007/s10350-007-9148-5

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  29 in total

1.  Number of lymph nodes after neoadjuvant therapy for rectal cancer: How many are needed?

Authors:  Stefano Scabini; Valter Ferrando
Journal:  World J Gastrointest Surg       Date:  2012-02-27

2.  Lymph node harvest in colon and rectal cancer: Current considerations.

Authors:  James R McDonald; Andrew G Renehan; Sarah T O'Dwyer; Najib Y Haboubi
Journal:  World J Gastrointest Surg       Date:  2012-01-27

3.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Yulia Lakhman; Romain Sudre; Richard K G Do; Frederic Bibeau; David Azria; Eric Assenat; Nicolas Molinari; Marie-Ange Pierredon; Philippe Rouanet; Boris Guiu
Journal:  Radiology       Date:  2016-02-26       Impact factor: 11.105

4.  Physician level reporting of surgical and pathology performance indicators: a regional study to assess feasibility and impact on quality.

Authors:  Craig McFadyen; Sara Lankshear; Dimitrios Divaris; Mark Berry; Amber Hunter; John Srigley; Jonathan Irish
Journal:  Can J Surg       Date:  2015-02       Impact factor: 2.089

5.  Laparoscopic TME associated with neoadjuvant chemoradiation towards aggressive colorectal cancer.

Authors:  Tao Yin; Dian-Sheng Cui; Zhi-Guo Xiong; Shao-Zhong Wei
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Less than 12 lymph nodes in the surgical specimen after neoadjuvant chemo-radiotherapy: an indicator of tumor regression in locally advanced rectal cancer?

Authors:  Jaiprakash Gurawalia; Kapil Dev; Sandeep P Nayak; Vishnu Kurpad; Arun Pandey
Journal:  J Gastrointest Oncol       Date:  2016-12

7.  Association of certification, improved quality and better oncological outcomes for rectal cancer in a specialized colorectal unit.

Authors:  Annika Jacob; Wolfgang Albert; Thomas Jackisch; Christiane Jakob; Anja Sims; Helmut Witzigmann; Sören Torge Mees; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2020-11-09       Impact factor: 2.571

8.  Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification?

Authors:  Thilo Sprenger; Hilka Rothe; Klaus Jung; Hans Christiansen; Lena C Conradi; B Michael Ghadimi; Heinz Becker; Torsten Liersch
Journal:  World J Surg Oncol       Date:  2010-04-13       Impact factor: 2.754

9.  An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all.

Authors:  M Medani; Niall Kelly; George Samaha; G Duff; Vourneen Healy; Elizabeth Mulcahy; Eoghan Condon; David Waldron; Jean Saunders; J Calvin Coffey
Journal:  Int J Colorectal Dis       Date:  2013-05-29       Impact factor: 2.571

10.  Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up.

Authors:  Thilo Sprenger; Hilka Rothe; Kia Homayounfar; Tim Beissbarth; B Michael Ghadimi; Heinz Becker; Torsten Liersch
Journal:  J Gastrointest Surg       Date:  2009-10-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.